The Drug Controller General of India (DCGI) has affirmed the utilization of hostile to viral medication Favipiravir for COVID-19 patients for confined use. The medication can be utilized distinctly if there should be an occurrence of a crisis and family assent of the patient is obligatory. The term of the course is 14 days. Glenmark…